u/Bailey-96 · 289d agono track record yet
IBRX (ImmunityBio) - Great squeeze potential
IBRX has exceptional short squeeze setup with ~40% float shorted, ~10 days to cover, and rising borrow costs, while the company releases multiple positive catalysts (lung cancer data, Saudi FDA approval, upcoming glioblastoma/CAR-NK data). Strong fundamentals including 424% YoY revenue growth and $257M cash eliminate bankruptcy risk, making a break above $3.00 a potential explosive move.
At post $3.02Now $8.29+174.5% since postedas of Oct 30, 4:45 PM ET
1d+30.8%
3d+82.8%
1w+129.1%
1m+96.9%
3m+151.7%
6m+157.9%
1y—